Loading
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 25 Mar 2026 for Vera Therapeutics, Inc.. Read the official filing
Insider track record
Disclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Jane Wright-Mitchell: trading record in brief
Jane Wright-Mitchell, listed as board member, has filed trades across 2 companies (mainly through SEC (Form 4)), most often in Vaxcyte, Inc. and Vera Therapeutics, Inc. The record holds 3 filings, for trades running from 12 August 2021 to 23 March 2026.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
The latest filing, published on 25 March 2026, reports a share grant in Vera Therapeutics, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. US insiders must file a Form 4 within two business days of a trade. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Jane Wright-Mitchell
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations3 total
42,403 shares0Class A Common StockSEC:0001614568-26-000008:0
2,500 shares@ US$2.0319.9% of flowCommon StockSEC:0001209191-21-052311:0
10,000 shares@ US$2.0380.1% of flowCommon StockSEC:0001209191-21-051631:0
3 of 3 declarations
